CA9 and colorectal carcinoma: Both KAE and cisplatin led to extensive reduction in the levels of Autotaxin, Carbonic Anhydrase IX, cathepsins, MMP-3, u-Plasminogen Activator/Urokinase, and HMOX1 in colorectal carcinoma cultures.